MIRM Stock: Price, Earnings History and SEC Filings
Mirum Pharmaceuticals, Inc. (MIRM) last traded at $85.00, down 1.61% on the latest session and down 0.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.80 against an analyst estimate of $-0.77, a miss of 3.9%.
$85.00 -1.61%
1 month-0.56%
52-week high$130.00
52-week low$63.23
Volume673,431
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MIRM earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.80 | $-0.77 | -3.90% |
| Mar 2026 | May 6, 2026 | $-0.39 | $-0.40 | +2.50% |
| Dec 2025 | Feb 25, 2026 | $-0.11 | $0.02 | -650.00% |
| Sep 2025 | Nov 4, 2025 | $0.05 | $-0.10 | +150.00% |
MIRM beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for MIRM
SEC filing data is not available right now. You can search for MIRM on SEC EDGAR.
MIRM news
- AnaptysBio (ANAB) vs. PTCT and MIRM: Is the Market Missing the Value of Its Royalty Stream and Legal Upside?Oct 31, 2026 · finance.yahoo.com
- Recursion Pharmaceuticals (RXRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 28, 2026 · finance.yahoo.com
- Mirum Pharmaceuticals (MIRM) Stock Trades Near Fair Value As Pediatric FOP Study ProgressesOct 28, 2026 · finance.yahoo.com
- Mirum Pharmaceuticals (MIRM) Could Be 44% Undervalued On Pediatric FOP Trial DataOct 28, 2026 · finance.yahoo.com
- Mirum Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 3, 2026Oct 27, 2026 · finance.yahoo.com
- Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 27, 2026 · finance.yahoo.com
- Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans ProgressivaOct 26, 2026 · finance.yahoo.com
- Mirum Pharmaceuticals to Participate in Upcoming Investor ConferencesOct 21, 2026 · finance.yahoo.com
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) is a US-listed public company on Nasdaq.